More articles from Review

The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
Scott F. Schoninger, Stacy W. Blain

Molecular Cancer Therapeutics Jan 2020, 19 (1) 3-12; DOI: 10.1158/1535-7163.MCT-19-0253
Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Paulo Bergerot, Peter Lamb, Evelyn Wang, Sumanta K. Pal

Molecular Cancer Therapeutics Dec 2019, 18 (12) 2185-2193; DOI: 10.1158/1535-7163.MCT-18-1399
Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
Benjamin L. Woolbright, Ganeshkumar Rajendran, Robert A. Harris, John A. Taylor

Molecular Cancer Therapeutics Oct 2019, 18 (10) 1673-1681; DOI: 10.1158/1535-7163.MCT-19-0079
DUBbing Down Translation: The Functional Interaction of Deubiquitinases with the Translational Machinery
Bandish B. Kapadia, Ronald B. Gartenhaus

Molecular Cancer Therapeutics Sep 2019, 18 (9) 1475-1483; DOI: 10.1158/1535-7163.MCT-19-0307
The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
Joshua Casaos, Noah L. Gorelick, Sakibul Huq, John Choi, Yuanxuan Xia, Riccardo Serra, Raphael Felder, Tarik Lott, Richard E. Kast, Ian Suk, Henry Brem, Betty Tyler, Nicolas Skuli

Molecular Cancer Therapeutics Jul 2019, 18 (7) 1185-1194; DOI: 10.1158/1535-7163.MCT-18-0666
What CAR Will Win the CD19 Race?
Alfonso Quintás-Cardama

Molecular Cancer Therapeutics Mar 2019, 18 (3) 498-506; DOI: 10.1158/1535-7163.MCT-18-1070
PET Imaging of Receptor Tyrosine Kinases in Cancer
Weijun Wei, Dalong Ni, Emily B. Ehlerding, Quan-Yong Luo, Weibo Cai

Molecular Cancer Therapeutics Aug 2018, 17 (8) 1625-1636; DOI: 10.1158/1535-7163.MCT-18-0087
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Arthur Winer, Sylvia Adams, Paolo Mignatti

Molecular Cancer Therapeutics Jun 2018, 17 (6) 1147-1155; DOI: 10.1158/1535-7163.MCT-17-0646
Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers
Masanori Kawakami, Lisa Maria Mustachio, Xi Liu, Ethan Dmitrovsky

Molecular Cancer Therapeutics Apr 2018, 17 (4) 724-731; DOI: 10.1158/1535-7163.MCT-17-1108
Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
Bayley A. Jones, Sooryanarayana Varambally, Rebecca C. Arend

Molecular Cancer Therapeutics Mar 2018, 17 (3) 591-602; DOI: 10.1158/1535-7163.MCT-17-0437

Main menu

User menu

Search

More articles from Review

Pages

Articles

Info for

About MCT